On this page

Cetirizine Hydrochloride (Allergy)

Cetirizine Hydrochloride · Tablet

Over-the-counter ANDA Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
Cetirizine Hydrochloride (Allergy)
Generic name
Cetirizine Hydrochloride
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA
Labeler
Aurohealth LLC
Product type
Human Otc Drug
DEA schedule
Not scheduled
Active ingredients
2
NDC product codes
17
Packages
72
Data completeness
82% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Cetirizine Hydrochloride 10 mg/1 1014678 View
Cetirizine Hydrochloride 5 mg/1 1014678 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Tablet
Route of administration
Oral
Presentations
89

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Histamine H1 Receptor Antagonists [MoA] MoA All 136 members
Histamine-1 Receptor Antagonist [EPC] EPC All 134 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
090760
Application type
ANDA · Abbreviated New Drug Application
Approval date
August 5, 2015
Sponsor
AUROBINDO PHARMA LTD
Products on application
4
Submissions recorded
1
Products approved under application 090760.
Product Trade name Form Strength Ingredient Status TE Flags
090760-001 CETIRIZINE HYDROCHLORIDE ALLERGY TABLET CETIRIZINE HYDROCHLORIDE Over-the-counter —
090760-002 CETIRIZINE HYDROCHLORIDE HIVES RELIEF TABLET CETIRIZINE HYDROCHLORIDE Over-the-counter —
090760-003 CETIRIZINE HYDROCHLORIDE ALLERGY TABLET CETIRIZINE HYDROCHLORIDE Over-the-counter —
090760-004 CETIRIZINE HYDROCHLORIDE HIVES RELIEF TABLET CETIRIZINE HYDROCHLORIDE Over-the-counter —

Approval history

Source: Drugs@FDA
Most recent submissions on application 090760.
Type No. Action Status Date Review
Original application 1 Approved August 5, 2015 —

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20260803). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN OTC DRUG · 20260803 HUMAN OTC DRUG · 20260129 HUMAN OTC DRUG · 20240301

Indications and Usage

openFDA Drug Labeling

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • itching of the nose or throat

Purpose Antihistamine

Dosage and Administration

openFDA Drug Labeling

Directions For 5 mg: adults and children 6 years and over 1 tablet (5 mg) or 2 tablets (10 mg) once daily depending upon severity of symptoms; do not take more than 2 tablets (10 mg) in 24 hours. adults 65 years and over 1 tablet (5 mg) once daily; do not take more than 1 tablet (5 mg) in 24 hours. children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor For 10 mg: adults and children 6 years and over one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms. adults 65 years and over ask a doctor children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

Ask a Doctor

openFDA Drug Labeling

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

Active Ingredient

openFDA Drug Labeling

Active ingredient (in each tablet) For 5 mg: Cetirizine hydrochloride USP 5 mg For 10 mg: Cetirizine hydrochloride USP 10 mg

How Supplied / Storage and Handling

openFDA Drug Labeling

HOW SUPPLIED Product: 50090-6168 NDC: 50090-6168-1 30 TABLET in a BOTTLE NDC: 50090-6168-3 90 TABLET in a BOTTLE

Adverse event reports

Source: openFDA FAERS
166,303
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: CETIRIZINE HYDROCHLORIDE. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
50090-6168-1 50090-6168 A-S Medication Solutions 30 TABLET in 1 BOTTLE (50090-6168-1) October 26, 2022
50090-6168-3 50090-6168 A-S Medication Solutions 90 TABLET in 1 BOTTLE (50090-6168-3) August 2, 2023
50090-6170-0 50090-6170 A-S Medication Solutions 48 BOTTLE in 1 CASE (50090-6170-0) / 30 TABLET in 1 BOTTLE October 13, 2022
50090-6950-0 50090-6950 A-S Medication Solutions 30 TABLET in 1 BOTTLE (50090-6950-0) December 19, 2023
50090-6950-1 50090-6950 A-S Medication Solutions 90 TABLET in 1 BOTTLE (50090-6950-1) January 28, 2026
58602-444-09 58602-444 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-444-09) / 30 TABLET in 1 BOTTLE August 5, 2015
58602-444-17 58602-444 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-444-17) / 45 TABLET in 1 BOTTLE August 5, 2015
58602-444-21 58602-444 Aurohealth LLC 10 BLISTER PACK in 1 CARTON (58602-444-21) / 10 TABLET in 1 BLISTER PACK August 5, 2015
58602-444-41 58602-444 Aurohealth LLC 1000 TABLET in 1 BOTTLE (58602-444-41) August 5, 2015
58602-444-47 58602-444 Aurohealth LLC 75 TABLET in 1 PACKAGE, COMBINATION (58602-444-47) August 5, 2015
58602-445-01 58602-445 Aurohealth LLC 1 BLISTER PACK in 1 CARTON (58602-445-01) / 14 TABLET in 1 BLISTER PACK August 5, 2015
58602-445-09 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-09) / 30 TABLET in 1 BOTTLE August 5, 2015
58602-445-15 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-15) / 60 TABLET in 1 BOTTLE August 5, 2015
58602-445-17 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-17) / 45 TABLET in 1 BOTTLE August 5, 2015
58602-445-19 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-19) / 90 TABLET in 1 BOTTLE August 5, 2015
58602-445-21 58602-445 Aurohealth LLC 10 BLISTER PACK in 1 CARTON (58602-445-21) / 10 TABLET in 1 BLISTER PACK August 5, 2015
58602-445-23 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-23) / 120 TABLET in 1 BOTTLE August 6, 2026
58602-445-38 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-38) / 300 TABLET in 1 BOTTLE August 5, 2015
58602-445-39 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-39) / 365 TABLET in 1 BOTTLE August 6, 2026
58602-445-40 58602-445 Aurohealth LLC 500 TABLET in 1 BOTTLE (58602-445-40) August 5, 2015
58602-445-41 58602-445 Aurohealth LLC 1000 TABLET in 1 BOTTLE (58602-445-41) August 5, 2015
58602-445-47 58602-445 Aurohealth LLC 75 TABLET in 1 PACKAGE, COMBINATION (58602-445-47) August 5, 2015
58602-445-54 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-54) / 70 TABLET in 1 BOTTLE August 5, 2015
58602-445-60 58602-445 Aurohealth LLC 1 BLISTER PACK in 1 CARTON (58602-445-60) / 5 TABLET in 1 BLISTER PACK August 5, 2015
58602-445-65 58602-445 Aurohealth LLC 2 BLISTER PACK in 1 CARTON (58602-445-65) / 7 TABLET in 1 BLISTER PACK November 21, 2019
58602-445-94 58602-445 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-445-94) / 100 TABLET in 1 BOTTLE August 5, 2015
58602-812-04 58602-812 Aurohealth LLC 10 BLISTER PACK in 1 CARTON (58602-812-04) / 10 TABLET in 1 BLISTER PACK (58602-812-83) August 5, 2015
58602-812-09 58602-812 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-812-09) / 30 TABLET in 1 BOTTLE August 5, 2015
58602-812-17 58602-812 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-812-17) / 45 TABLET in 1 BOTTLE August 5, 2015
58602-812-23 58602-812 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-812-23) / 120 TABLET in 1 BOTTLE August 5, 2015
58602-812-39 58602-812 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-812-39) / 365 TABLET in 1 BOTTLE August 5, 2015
58602-812-41 58602-812 Aurohealth LLC 1000 TABLET in 1 BOTTLE (58602-812-41) August 5, 2015
58602-812-99 58602-812 Aurohealth LLC 75 TABLET in 1 PACKAGE, COMBINATION (58602-812-99) August 5, 2015
58602-823-39 58602-823 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-823-39) / 365 TABLET in 1 BOTTLE August 5, 2015
58602-861-40 58602-861 Aurohealth LLC 500 TABLET in 1 BOTTLE (58602-861-40) May 25, 2026
21130-098-23 21130-098 Better Living Brands, LLC 1 BOTTLE in 1 CARTON (21130-098-23) / 120 TABLET in 1 BOTTLE February 10, 2023
68001-436-04 68001-436 BluePoint Laboratories 1 BOTTLE in 1 CARTON (68001-436-04) / 30 TABLET in 1 BOTTLE June 19, 2020
68001-436-96 68001-436 BluePoint Laboratories 10 BLISTER PACK in 1 CARTON (68001-436-96) / 10 TABLET in 1 BLISTER PACK (68001-436-16) June 19, 2020
68001-436-97 68001-436 BluePoint Laboratories 1 BOTTLE in 1 CARTON (68001-436-97) / 300 TABLET in 1 BOTTLE June 19, 2020
69842-237-01 69842-237 CVS Pharmacy, Inc. 1 BLISTER PACK in 1 CARTON (69842-237-01) / 14 TABLET in 1 BLISTER PACK July 26, 2019
69842-237-09 69842-237 CVS Pharmacy, Inc. 1 BOTTLE in 1 CARTON (69842-237-09) / 30 TABLET in 1 BOTTLE July 26, 2019
69842-237-17 69842-237 CVS Pharmacy, Inc. 1 BOTTLE in 1 CARTON (69842-237-17) / 45 TABLET in 1 BOTTLE July 26, 2019
69842-237-19 69842-237 CVS Pharmacy, Inc. 1 BOTTLE in 1 CARTON (69842-237-19) / 90 TABLET in 1 BOTTLE July 26, 2019
69842-237-23 69842-237 CVS Pharmacy, Inc. 1 BOTTLE in 1 CARTON (69842-237-23) / 120 TABLET in 1 BOTTLE July 26, 2019
69842-237-39 69842-237 CVS Pharmacy, Inc. 365 TABLET in 1 BOTTLE (69842-237-39) July 26, 2019
69842-237-45 69842-237 CVS Pharmacy, Inc. 2 BOTTLE in 1 CARTON (69842-237-45) / 120 TABLET in 1 BOTTLE July 26, 2019
57483-190-14 57483-190 INNOVUS PHARMACEUTICALS, INC. 365 TABLET in 1 BOTTLE (57483-190-14) April 28, 2025
30142-172-09 30142-172 KROGER COMPANY 1 BOTTLE in 1 CARTON (30142-172-09) / 30 TABLET in 1 BOTTLE March 15, 2021
30142-172-54 30142-172 KROGER COMPANY 1 BOTTLE in 1 CARTON (30142-172-54) / 70 TABLET in 1 BOTTLE March 15, 2021
16714-799-01 16714-799 NorthStar Rx LLC 30 TABLET in 1 BOTTLE (16714-799-01) August 5, 2015
16714-799-02 16714-799 NorthStar Rx LLC 100 TABLET in 1 BOTTLE (16714-799-02) August 5, 2015
16714-799-03 16714-799 NorthStar Rx LLC 300 TABLET in 1 BOTTLE (16714-799-03) August 5, 2015
16714-799-04 16714-799 NorthStar Rx LLC 500 TABLET in 1 BOTTLE (16714-799-04) August 5, 2015
68788-8204-0 68788-8204 Preferred Pharmaceuticals Inc. 100 TABLET in 1 BOTTLE (68788-8204-0) April 1, 2022
68788-8204-1 68788-8204 Preferred Pharmaceuticals Inc. 14 TABLET in 1 BOTTLE (68788-8204-1) April 1, 2022
68788-8204-3 68788-8204 Preferred Pharmaceuticals Inc. 30 TABLET in 1 BOTTLE (68788-8204-3) April 1, 2022
68788-8204-5 68788-8204 Preferred Pharmaceuticals Inc. 15 TABLET in 1 BOTTLE (68788-8204-5) April 1, 2022
68788-8204-6 68788-8204 Preferred Pharmaceuticals Inc. 60 TABLET in 1 BOTTLE (68788-8204-6) April 1, 2022
68788-8204-9 68788-8204 Preferred Pharmaceuticals Inc. 90 TABLET in 1 BOTTLE (68788-8204-9) April 1, 2022
71205-700-00 71205-700 Proficient Rx LP 100 TABLET in 1 BOTTLE (71205-700-00) March 8, 2024
71205-700-06 71205-700 Proficient Rx LP 6 TABLET in 1 BOTTLE (71205-700-06) January 29, 2024
71205-700-10 71205-700 Proficient Rx LP 10 TABLET in 1 BOTTLE (71205-700-10) October 20, 2022
71205-700-12 71205-700 Proficient Rx LP 12 TABLET in 1 BOTTLE (71205-700-12) January 29, 2024
71205-700-14 71205-700 Proficient Rx LP 14 TABLET in 1 BOTTLE (71205-700-14) January 29, 2024
71205-700-15 71205-700 Proficient Rx LP 15 TABLET in 1 BOTTLE (71205-700-15) January 29, 2024
71205-700-20 71205-700 Proficient Rx LP 20 TABLET in 1 BOTTLE (71205-700-20) January 29, 2024
71205-700-21 71205-700 Proficient Rx LP 21 TABLET in 1 BOTTLE (71205-700-21) January 29, 2024
71205-700-30 71205-700 Proficient Rx LP 30 TABLET in 1 BOTTLE (71205-700-30) September 16, 2022
71205-700-60 71205-700 Proficient Rx LP 60 TABLET in 1 BOTTLE (71205-700-60) September 16, 2022
71205-700-72 71205-700 Proficient Rx LP 120 TABLET in 1 BOTTLE (71205-700-72) March 8, 2024
71205-700-90 71205-700 Proficient Rx LP 90 TABLET in 1 BOTTLE (71205-700-90) September 16, 2022
0363-9602-09 0363-9602 WALGREEN CO. 1 BOTTLE in 1 CARTON (0363-9602-09) / 30 TABLET in 1 BOTTLE July 5, 2021
50090-6168 50090-6168 A-S Medication Solutions — August 5, 2015
50090-6170 50090-6170 A-S Medication Solutions — August 5, 2015
50090-6950 50090-6950 A-S Medication Solutions — August 5, 2015
58602-444 58602-444 Aurohealth LLC — August 5, 2015
58602-445 58602-445 Aurohealth LLC — August 5, 2015
58602-812 58602-812 Aurohealth LLC — August 5, 2015
58602-823 58602-823 Aurohealth LLC — August 5, 2015
58602-861 58602-861 Aurohealth LLC — February 10, 2023
21130-098 21130-098 Better Living Brands, LLC — February 10, 2023
68001-436 68001-436 BluePoint Laboratories — June 19, 2020
69842-237 69842-237 CVS Pharmacy, Inc. — July 26, 2019
57483-190 57483-190 INNOVUS PHARMACEUTICALS, INC. — April 28, 2025
30142-172 30142-172 KROGER COMPANY — March 15, 2021
16714-799 16714-799 NorthStar Rx LLC — August 5, 2015
68788-8204 68788-8204 Preferred Pharmaceuticals Inc. — April 1, 2022
71205-700 71205-700 Proficient Rx LP — August 5, 2015
0363-9602 0363-9602 WALGREEN CO. — July 5, 2021

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts

Generated September 25, 2026 · 11 sections on this page.